Avalo Therapeutics Inc. (AVTX)
NASDAQ · Healthcare
Avalo Therapeutics Inc. Long Term Debt 2015–2025
Avalo Therapeutics Inc. annual long term debt history from 2015 to 2018. Long term debt refers to financial obligations that are due more than one year in the future.
- Avalo Therapeutics Inc. long term debt as of December 31, 2018: 14.3M, a 508.80% increase year-over-year.
- Avalo Therapeutics Inc. long term debt for 2018 were 14.3M, a 508.80% increase from 2015.
- Avalo Therapeutics Inc. long term debt for 2015 were 2.4M.
Long Term Debt
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Avalo Therapeutics Inc. Annual Long Term Debt (Millions of US $) | |
|---|---|
| 2018 | $14 |
| 2015 | $2 |
Avalo Therapeutics Inc. Long Term Debt — FAQ
Avalo Therapeutics Inc. (AVTX) long term debt over the last 11 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see AVTX's long term debt history?
The chart and table above show Avalo Therapeutics Inc.'s long term debt by year and by quarter, including the growth rate.